Abstract
Purpose
To compare pregnancy, delivery, and neonatal outcomes in patients with polycystic ovary syndrome (PCOS) with and without concomitant hypothyroidism.
Methods
A retrospective population-based cohort study including all women with an ICD-9 diagnosis of PCOS in the US between 2004 and 2014, who delivered in the third trimester or had a maternal death. We compared women with a concomitant diagnosis of hypothyroidism to those without. Women with hyperthyroidism were excluded. Pregnancy, delivery, and neonatal outcomes were compared between the two groups.
Results
Overall, 14,882 women met inclusion criteria. Among them, 1882 (12.65%) had a concomitant diagnosis of hypothyroidism, and 13,000 (87.35%) did not. Women with concomitant hypothyroidism, compared to those without, were characterized by increased maternal age (25.5% ≥ 35 years vs. 18%, p < 0.001, respectively), and had a higher rate of multiple gestations (7.1% vs. 5.7%, p = 0.023). Interestingly, pregnancy, delivery and neonatal outcomes were comparable between the groups, except for a higher rate of small-for-gestational-age (SGA) neonates in the group with hypothyroidism (4.1% vs. 3.2%, p = 0.033) (Tables 2 and 3). In a multivariate logistic regression adjusting for potential confounders, hypothyroidism was no longer found to be associated with SGA (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 0.99–1.75, p = 0.057), but was found to increase the odds for preeclampsia (aOR 1.30, 95% CI 1.06–1.59, p = 0.012).
Conclusions
In patients with PCOS, concomitant hypothyroidism significantly increases the risk for preeclampsia. Unexpectedly, other pregnancy complications commonly increased by hypothyroidism were not increased in women with PCOS, likely due to the inherent elevated baseline pregnancy risks of PCOS.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the authors upon reasonable request.
References
Bozdag G, Mumusoglu S, Zengin D et al (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841–2855. https://doi.org/10.1093/humrep/dew218
Fernandez RC, Moore VM, Rumbold AR et al (2021) Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod 36:2275–2284. https://doi.org/10.1093/humrep/deab101
Zeng X, Xie YJ, Liu YT et al (2020) Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta 502:214–221. https://doi.org/10.1016/j.cca.2019.11.003
Yu HF, Chen HS, Rao DP, Gong J (2016) Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e4863. https://doi.org/10.1097/MD.0000000000004863
Morris A (2020) Transgenerational effects of polycystic ovary syndrome identified. Nat Rev Endocrinol 16:67. https://doi.org/10.1038/s41574-019-0314-3
Dahan MH, Reaven G (2019) Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine 64:685–689. https://doi.org/10.1007/s12020-019-01899-9
Palomba S, Santagni S, Falbo A, la Sala GB (2015) Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 7:745–763. https://doi.org/10.2147/IJWH.S70314
Subramanian A, Lee SI, Phillips K et al (2022) Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England. BMC Med 20:298. https://doi.org/10.1186/s12916-022-02473-3
Kollmann M, Klaritsch P, Martins WP et al (2015) Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod 30:2396–2403. https://doi.org/10.1093/humrep/dev187
Mills G, Badeghiesh A, Suarthana E et al (2020) Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births. Hum Reprod 35:1914–1921. https://doi.org/10.1093/humrep/deaa144
Mills G, Badeghiesh A, Suarthana E et al (2020) Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod 35:1666–1674. https://doi.org/10.1093/humrep/deaa099
Peeva M, Badeghiesh A, Baghlaf H, Dahan MH (2022) Association between obesity in women with polycystic ovary syndrome and adverse obstetric outcomes. Reprod Biomed Online 45:159–167. https://doi.org/10.1016/j.rbmo.2022.02.007
Dosiou C (2020) Thyroid and fertility: recent advances. Thyroid 30:479–486. https://doi.org/10.1089/thy.2019.0382
Janssen OE, Mehlmauer N, Hahn S et al (2004) High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 150:363–369. https://doi.org/10.1530/eje.0.1500363
Garelli S, Masiero S, Plebani M et al (2013) High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 169:248–251. https://doi.org/10.1016/j.ejogrb.2013.03.003
Fatima M, Amjad S, AliSr HS et al (2020) Correlation of subclinical hypothyroidism with polycystic ovary syndrome (PCOS). Cureus 12:e8142. https://doi.org/10.7759/cureus.8142
Ho CW, Chen HH, Hsieh MC et al (2020) Increased Risk of Polycystic Ovary Syndrome and It’s Comorbidities in Women with Autoimmune Thyroid Disease. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph17072422
Ding X, Yang L, Wang J et al (2018) Subclinical hypothyroidism in polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 9:700. https://doi.org/10.3389/fendo.2018.00700
Romitti M, Fabris VC, Ziegelmann PK et al (2018) Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis. Endocr Connect 7:1158–1167. https://doi.org/10.1530/EC-18-0309
Gaberscek S, Zaletel K, Schwetz V et al (2015) Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur J Endocrinol 172:R9-21. https://doi.org/10.1530/EJE-14-0295
van der Spek AH, Bisschop PH (2020) Universal screening for thyroid disease SHOULD NOT be recommended before and during pregnancy. Best Pract Res Clin Endocrinol Metab 34:101429. https://doi.org/10.1016/j.beem.2020.101429
Ge GM, Leung MTY, Man KKC et al (2020) Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: a systematic review and meta-analysis. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa555
Haddow JE, Palomaki GE, Allan WC et al (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549–555. https://doi.org/10.1056/NEJM199908193410801
Liu X, Andersen SL, Olsen J et al (2018) Maternal hypothyroidism in the perinatal period and childhood asthma in the offspring. Allergy 73:932–939. https://doi.org/10.1111/all.13365
Thorpe-Beeston JG, Nicolaides KH, Felton C, v, et al (1991) Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324:532–536. https://doi.org/10.1056/NEJM199102213240805
Dhillon-Smith RK, Coomarasamy A (2020) TPO antibody positivity and adverse pregnancy outcomes. Best Pract Res Clin Endocrinol Metab 34:101433. https://doi.org/10.1016/j.beem.2020.101433
Meena A, Nagar P (2016) Pregnancy outcome in euthyroid women with anti-thyroid peroxidase antibodies. J Obstet Gynaecol India 66:160–165. https://doi.org/10.1007/s13224-014-0657-6
Maraka S, Ospina NM, O’Keeffe DT et al (2016) Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 26:580–590. https://doi.org/10.1089/thy.2015.0418
Derakhshan A, Peeters RP, Taylor PN et al (2020) Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol 8:501–510. https://doi.org/10.1016/S2213-8587(20)30061-9
Lee SY, Cabral HJ, Aschengrau A, Pearce EN (2020) Associations between maternal thyroid function in pregnancy and obstetric and perinatal outcomes. J Clin Endocrinol Metab 105:e2015–e2023. https://doi.org/10.1210/clinem/dgz275
Luo J, Yuan J (2022) Effects of levothyroxine therapy on pregnancy and neonatal outcomes in subclinical hypothyroidism. Int J Gen Med 15:6811–6820. https://doi.org/10.2147/IJGM.S366981
Pradhan M, Anand B, Singh N, Mehrotra M (2013) Thyroid peroxidase antibody in hypothyroidism: it’s effect on pregnancy. J Matern Fetal Neonatal Med 26:581–583. https://doi.org/10.3109/14767058.2012.745498
Yuan N, Sun J, Li Z et al (2020) Relationship between anti-thyroid peroxidase antibody positivity and pregnancy-related and fetal outcomes in Euthyroid women: a single-center cohort study. BMC Pregnancy Childbirth 20:491. https://doi.org/10.1186/s12884-020-03176-4
Beharier O, Walfisch A, Wainstock T et al (2020) Maternal hypothyroidism during pregnancy and the risk for infectious morbidity of the Offspring. Am J Perinatol 37:291–295. https://doi.org/10.1055/S-0039-3400980
Gutvirtz G, Walfisch A, Wainstock T et al (2019) Maternal hypothyroidism and future pediatric neurological morbidity of the offspring. Arch Gynecol Obstet. https://doi.org/10.1007/S00404-019-05092-1
(2018) Tri-Council Policy Statement
Singla R, Gupta Y, Khemani M, Aggarwal S (2015) Thyroid disorders and polycystic ovary syndrome: an emerging relationship. Indian J Endocrinol Metab 19:25–29. https://doi.org/10.4103/2230-8210.146860
Springer D, Jiskra J, Limanova Z et al (2017) Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci 54:102–116. https://doi.org/10.1080/10408363.2016.1269309
Sterrett M (2019) Maternal and fetal thyroid physiology. Clin Obstet Gynecol 62:302–307. https://doi.org/10.1097/GRF.0000000000000439
Kjerulff LE, Sanchez-Ramos L, Duffy D (2011) Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 204(558):e1-6. https://doi.org/10.1016/j.ajog.2011.03.021
Taylor PN, Lazarus JH (2019) Hypothyroidism in pregnancy. Endocrinol Metab Clin North Am 48:547–556. https://doi.org/10.1016/j.ecl.2019.05.010
Korevaar TIM, Medici M, Visser TJ, Peeters RP (2017) Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 13:610–622. https://doi.org/10.1038/nrendo.2017.93
Luewan S, Chakkabut P, Tongsong T (2011) Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 283:243–247. https://doi.org/10.1007/s00404-010-1362-z
Mannisto T, Mendola P, Grewal J et al (2013) Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab 98:2725–2733. https://doi.org/10.1210/jc.2012-4233
Adu-Gyamfi EA, Wang YX, Ding YB (2020) The interplay between thyroid hormones and the placenta: a comprehensive reviewdagger. Biol Reprod 102:8–17. https://doi.org/10.1093/biolre/ioz182
Burggraaf J, Lalezari S, Emeis JJ et al (2001) Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 11:153–160. https://doi.org/10.1089/105072501300042820
Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501–509. https://doi.org/10.1056/NEJM200102153440707
Mannisto T, Vaarasmaki M, Pouta A et al (2010) Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 95:1084–1094. https://doi.org/10.1210/jc.2009-1904
Toloza FJK, Derakhshan A, Mannisto T et al (2022) Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol 10:243–252. https://doi.org/10.1016/S2213-8587(22)00007-9
Feigl S, Obermayer-Pietsch B, Klaritsch P et al (2022) Impact of thyroid function on pregnancy and neonatal outcome in women with and without PCOS. Biomedicines. https://doi.org/10.3390/biomedicines10040750
Trouva A, Alvarsson M, Calissendorff J et al (2022) Thyroid status during pregnancy in women with polycystic ovary syndrome and the effect of metformin. Front Endocrinol (Lausanne) 13:772801. https://doi.org/10.3389/fendo.2022.772801
Benetti-Pinto CL, Berini Piccolo VR, Garmes HM, Teatin Juliato CR (2013) Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters. Fertil Steril 99:588–592. https://doi.org/10.1016/j.fertnstert.2012.10.006
Ganie MA, Laway BA, Wani TA et al (2011) Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertil Steril 95:2039–2043. https://doi.org/10.1016/j.fertnstert.2011.01.149
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by AH, AB, HB and MD. The first draft of the manuscript was written by AH and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. AH – Protocol and project development; data selection and management; data analysis; manuscript writing and editing. AB—Protocol and project development; Data selection and management; data analysis; manuscript editing. HB—Protocol and project development; Data selection and management; data analysis; manuscript editing. MD—Protocol and project development; data selection and management; data analysis; manuscript writing and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study used exclusively publicly accessible, anonymized data; therefore, according to articles 2.2 and 2.4 of Tri-Council Policy Statement (2010), institutional review board approval was not required.
Consent to participate
Informed consent was waived due to the retrospective design of the study.
Consent to publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hochberg, A., Badeghiesh, A., Baghlaf, H. et al. The association between hypothyroidism and perinatal outcomes in patients with polycystic ovary syndrome. Arch Gynecol Obstet 308, 291–299 (2023). https://doi.org/10.1007/s00404-023-07063-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07063-z